{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:26:24Z","timestamp":1781565984264,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40266-024-01160-7","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T06:47:37Z","timestamp":1732344457000},"page":"989-1001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a Frailty Screening Tool Using Electronic Community Pharmacy Records"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2133-1215","authenticated-orcid":false,"given":"Marie","family":"Carrein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Mehuys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"Lahousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Van Tongelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Tommelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Boussery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"issue":"9868","key":"1160_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. The Lancet. 2013;381(9868):752\u201362.","journal-title":"The Lancet"},{"issue":"1","key":"1160_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cger.2017.09.004","volume":"34","author":"J Walston","year":"2018","unstructured":"Walston J, Buta B, Xue QL. Frailty screening and interventions: considerations for clinical practice. Clin Geriatr Med. 2018;34(1):25\u201338.","journal-title":"Clin Geriatr Med"},{"issue":"12","key":"1160_CR3","doi-asserted-by":"publisher","first-page":"1163.e1-.e17","DOI":"10.1016\/j.jamda.2016.09.010","volume":"17","author":"S Vermeiren","year":"2016","unstructured":"Vermeiren S, Vella-Azzopardi R, Beckw\u00e9e D, et al. Frailty and the prediction of negative health outcomes: a meta-analysis. J Am Med Dir Assoc. 2016;17(12):1163.e1-.e17.","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"1160_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40266-022-00940-3","volume":"39","author":"JYJ Lam","year":"2022","unstructured":"Lam JYJ, Barras M, Scott IA, et al. Scoping review of studies evaluating frailty and its association with medication harm. Drugs Aging. 2022;39(5):333\u201353.","journal-title":"Drugs Aging"},{"issue":"5","key":"1160_CR5","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1016\/S2666-7568(23)00036-3","volume":"4","author":"R Daunt","year":"2023","unstructured":"Daunt R, Curtin D, O\u2019Mahony D. Polypharmacy stewardship: a novel approach to tackle a major public health crisis. Lancet Healthy Longev. 2023;4(5):e228\u201335.","journal-title":"Lancet Healthy Longev."},{"key":"1160_CR6","unstructured":"Eurostat. Ageing Europe-Statistics on population developments. https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Ageing_Europe_-_statistics_on_population_developments. Accessed 20 Jan 2024."},{"issue":"8","key":"1160_CR7","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1111\/jgs.18343","volume":"71","author":"L Ye","year":"2023","unstructured":"Ye L, Nieboer D, Yang-Huang J, et al. The association between frailty and the risk of medication-related problems among community-dwelling older adults in Europe. J Am Geriatr Soc. 2023;71(8):2485\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"1160_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s40266-022-00952-z","volume":"39","author":"MA Randles","year":"2022","unstructured":"Randles MA, O\u2019Mahony D, Gallagher PF. Frailty and potentially inappropriate prescribing in older people with polypharmacy: a bi-directional relationship? Drugs Aging. 2022;39(8):597\u2013606.","journal-title":"Drugs Aging"},{"key":"1160_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101811","volume":"83","author":"JJY Toh","year":"2023","unstructured":"Toh JJY, Zhang H, Soh YY, et al. Prevalence and health outcomes of polypharmacy and hyperpolypharmacy in older adults with frailty: a systematic review and meta-analysis. Ageing Res Rev. 2023;83: 101811.","journal-title":"Ageing Res Rev"},{"issue":"7","key":"1160_CR10","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/bcp.13590","volume":"84","author":"M Gutierrez-Valencia","year":"2018","unstructured":"Gutierrez-Valencia M, Izquierdo M, Cesari M, et al. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84(7):1432\u201344.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1160_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s41999-018-0124-5","volume":"10","author":"K Palmer","year":"2019","unstructured":"Palmer K, Villani ER, Vetrano DL, et al. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med. 2019;10(1):9\u201336.","journal-title":"Eur Geriatr Med."},{"issue":"3","key":"1160_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/ijcp.12313","volume":"68","author":"TJ Welsh","year":"2014","unstructured":"Welsh TJ, Gordon AL, Gladman JR. Comprehensive geriatric assessment-a guide for the non-specialist. Int J Clin Pract. 2014;68(3):290\u20133.","journal-title":"Int J Clin Pract"},{"key":"1160_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2021.104612","volume":"99","author":"A Lim","year":"2022","unstructured":"Lim A, Choi J, Ji H, et al. Frailty assessment using routine clinical data: an integrative review. Arch Gerontol Geriatr. 2022;99: 104612.","journal-title":"Arch Gerontol Geriatr"},{"issue":"4","key":"1160_CR14","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.18549\/PharmPract.2020.4.1976","volume":"18","author":"B Abrahamsen","year":"2020","unstructured":"Abrahamsen B, Hansen RN, Rossing C. For which patient subgroups are there positive outcomes from a medication review? A systematic review. Pharm Pract (Granada). 2020;18(4):1976.","journal-title":"Pharm Pract (Granada)."},{"key":"1160_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KGM, Dhiman P, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385: e078378.","journal-title":"BMJ"},{"issue":"1","key":"1160_CR16","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1-73.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1160_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006645","volume":"4","author":"R Romero-Ortuno","year":"2014","unstructured":"Romero-Ortuno R, Soraghan C. A Frailty Instrument for primary care for those aged 75 years or more: findings from the Survey of Health, Ageing and Retirement in Europe, a longitudinal population-based cohort study (SHARE-FI75+). BMJ Open. 2014;4(12): e006645.","journal-title":"BMJ Open"},{"issue":"3","key":"1160_CR18","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146\u201356.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1160_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2015.12.003","volume":"26","author":"BJ Buta","year":"2016","unstructured":"Buta BJ, Walston JD, Godino JG, et al. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26:53\u201361.","journal-title":"Ageing Res Rev"},{"key":"1160_CR20","unstructured":"WHO. ATC\/DDD Index: collaborating centre for drug statistics methodology. Norwegian Institute of Public Health.; 2023. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"issue":"4","key":"1160_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-021122","volume":"8","author":"NL Pratt","year":"2018","unstructured":"Pratt NL, Kerr M, Barratt JD, et al. The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System. BMJ Open. 2018;8(4): e021122.","journal-title":"BMJ Open"},{"issue":"7","key":"1160_CR22","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2468-2667(18)30091-4","volume":"3","author":"P Hanlon","year":"2018","unstructured":"Hanlon P, Nicholl BI, Jani BD, et al. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health. 2018;3(7):e323\u201332.","journal-title":"Lancet Public Health."},{"issue":"7","key":"1160_CR23","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","volume":"55","author":"JB Segal","year":"2017","unstructured":"Segal JB, Chang HY, Du Y, et al. Development of a claims-based frailty indicator anchored to a well-established frailty phenotype. Med Care. 2017;55(7):716\u201322.","journal-title":"Med Care"},{"issue":"10","key":"1160_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032597","volume":"9","author":"KK Jacobsen","year":"2019","unstructured":"Jacobsen KK, Jepsen R, Lembeck MA, et al. Associations between the SHARE frailty phenotype and common frailty characteristics: evidence from a large Danish population study. BMJ Open. 2019;9(10): e032597.","journal-title":"BMJ Open"},{"key":"1160_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101789","volume":"84","author":"D Kaskirbayeva","year":"2023","unstructured":"Kaskirbayeva D, West R, Jaafari H, et al. Progression of frailty as measured by a cumulative deficit index: a systematic review. Ageing Res Rev. 2023;84: 101789.","journal-title":"Ageing Res Rev"},{"key":"1160_CR26","doi-asserted-by":"publisher","first-page":"1605964","DOI":"10.3389\/ijph.2023.1605964","volume":"68","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Li Y, Gao Q, et al. Prevalence of frailty among chinese community-dwelling older adults: a systematic review and meta-analysis. Int J Public Health. 2023;68:1605964.","journal-title":"Int J Public Health"},{"key":"1160_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101048","volume":"59","author":"G Kojima","year":"2020","unstructured":"Kojima G, Taniguchi Y, Kitamura A, et al. Is living alone a risk factor of frailty? A systematic review and meta-analysis. Ageing Res Rev. 2020;59: 101048.","journal-title":"Ageing Res Rev"},{"key":"1160_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12877-015-0134-9","volume":"15","author":"G Kojima","year":"2015","unstructured":"Kojima G, Iliffe S, Walters K. Smoking as a predictor of frailty: a systematic review. BMC Geriatr. 2015;15:131.","journal-title":"BMC Geriatr"},{"issue":"5","key":"1160_CR29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12603-019-1179-9","volume":"23","author":"B He","year":"2019","unstructured":"He B, Ma Y, Wang C, et al. Prevalence and risk factors for frailty among community-dwelling older people in China: a systematic review and meta-analysis. J Nutr Health Aging. 2019;23(5):442\u201350.","journal-title":"J Nutr Health Aging"},{"key":"1160_CR30","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","volume":"185","author":"S Katz","year":"1963","unstructured":"Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914\u20139.","journal-title":"JAMA"},{"issue":"3","key":"1160_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1525-1497.2005.00291.x","volume":"21","author":"KB DeSalvo","year":"2006","unstructured":"DeSalvo KB, Bloser N, Reynolds K, et al. Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med. 2006;21(3):267\u201375.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"1160_CR32","first-page":"1733","volume":"23","author":"CB Terwee","year":"2014","unstructured":"Terwee CB, Roorda LD, de Vet HC, et al. Dutch-Flemish translation of 17 item banks from the patient-reported outcomes measurement information system (PROMIS). Qual Life Res. 2014;23(6):1733\u201341.","journal-title":"Qual Life Res"},{"key":"1160_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fnagi.2015.00056","volume":"7","author":"T Coelho","year":"2015","unstructured":"Coelho T, Pa\u00fal C, Gobbens RJ, et al. Determinants of frailty: the added value of assessing medication. Front Aging Neurosci. 2015;7:56.","journal-title":"Front Aging Neurosci."},{"issue":"6","key":"1160_CR34","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/MAT.0000000000001894","volume":"69","author":"C Heaney","year":"2023","unstructured":"Heaney C, Knisel A, Vuthoori R, et al. Subjective assessment underestimates fraility in patients with heart failure referred for advanced therapies. Asaio J. 2023;69(6):588\u201394.","journal-title":"Asaio J"},{"issue":"8","key":"1160_CR35","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00192-019-04095-5","volume":"31","author":"JK Shinnick","year":"2020","unstructured":"Shinnick JK, Raker CA, Sung V. Provider miscategorization of frailty in an outpatient urogynecologic population. Int Urogynecol J. 2020;31(8):1529\u201335.","journal-title":"Int Urogynecol J"},{"key":"1160_CR36","doi-asserted-by":"publisher","first-page":"233372142090423","DOI":"10.1177\/2333721420904234","volume":"6","author":"YL Hu","year":"2020","unstructured":"Hu YL, Patel P, Fritz H. Detecting prefrailty: comparing subjective frailty assessment and the paulson-lichtenberg frailty index. Gerontol Geriatr Med. 2020;6:2333721420904234.","journal-title":"Gerontol Geriatr Med."},{"issue":"9","key":"1160_CR37","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.hlc.2022.04.003","volume":"31","author":"J McDonagh","year":"2022","unstructured":"McDonagh J, Prichard R, Ferguson C, et al. Clinician estimates of frailty compared to formal frailty assessment in adults with heart failure: a cross-sectional analysis. Heart Lung Circ. 2022;31(9):1241\u20136.","journal-title":"Heart Lung Circ"},{"issue":"1","key":"1160_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/24748706.2018.1524610","volume":"3","author":"P Green","year":"2019","unstructured":"Green P, Chung CJ, Oberweis BS, et al. The \u201cEyeball Test\u201d for risk assessment in aortic stenosis: characterizing subjective frailty using objective measures. Structural Heart. 2019;3(1):44\u201352.","journal-title":"Structural Heart."},{"issue":"1","key":"1160_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12875-018-0743-4","volume":"19","author":"C Korenvain","year":"2018","unstructured":"Korenvain C, Famiyeh IM, Dunn S, et al. Identifying frailty in primary care: a qualitative description of family physicians\u2019 gestalt impressions of their older adult patients. BMC Fam Pract. 2018;19(1):61.","journal-title":"BMC Fam Pract"},{"issue":"6","key":"1160_CR40","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/gerona\/glz260","volume":"75","author":"RC Ambagtsheer","year":"2020","unstructured":"Ambagtsheer RC, Visvanathan R, Dent E, et al. Commonly used screening instruments to identify frailty among community-dwelling older people in a general practice (primary care) setting: a study of diagnostic test accuracy. J Gerontol A Biol Sci Med Sci. 2020;75(6):1134\u201342.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"1160_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jamda.2020.05.004","volume":"22","author":"SJ Liau","year":"2021","unstructured":"Liau SJ, Lalic S, Sluggett JK, et al. Medication management in frail older people: consensus principles for clinical practice, research, and education. J Am Med Dir Assoc. 2021;22(1):43\u20139.","journal-title":"J Am Med Dir Assoc"},{"issue":"9","key":"1160_CR42","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12603-019-1273-z","volume":"23","author":"E Dent","year":"2019","unstructured":"Dent E, Morley JE, Cruz-Jentoft AJ, et al. Physical frailty: ICFSR international clinical practice guidelines for identification and management. J Nutr Health Aging. 2019;23(9):771\u201387.","journal-title":"J Nutr Health Aging"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01160-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01160-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01160-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T21:37:46Z","timestamp":1733953066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01160-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1160"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01160-7","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"28 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding sources were provided.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Outside this manuscript, L.L. has been consulted as an expert for AstraZeneca, GSK and SANOFI; supported for travel by Menarini; and has given lectures sponsored by Chiesi, IPSA vzw and Domus Medica vzw (non-profit organizations facilitating lifelong learning for health care providers), all paid to her institution. MP is an Editorial Board member of Drugs & Aging. MP was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Data supporting this study are not publicly available to preserve individuals\u2019 privacy under the European General Data Protection Regulation. Data are available from the corresponding author upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Approval for the study was granted by the ethics committee of Ghent University Hospital (B670201941411). The study was conducted according to Good Clinical Practice (ICH\/GCP) guidelines and the Declaration of Helsinki established to protect people participating in clinical trials.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All participants gave written informed consent.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors have approved the submission of this manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}